Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anticoagulation in COVID-19 ARDS”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Post-approval studies (Phase 4)UnknownNCT04445935
What this trial is testing

Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial

Who this might be right for
Anticoagulation in COVID-19 ARDS
Hamad Medical Corporation 100
Not applicableStudy completedNCT06038682
What this trial is testing

Monitoring Anticoagulation in Patients on ECMO for Severe Lung Failure

Who this might be right for
ARDSCOVID-19
University Hospital Ostrava 100
Testing effectiveness (Phase 2)Study completedNCT04505592
What this trial is testing

Tenecteplase in Patients With COVID-19

Who this might be right for
COVID-19Respiratory FailureARDS
Hooman Poor 13
Not applicableStudy completedNCT04998799
What this trial is testing

Practice Variation on Antithrombotics in COVID-19

Who this might be right for
COVID-19 PneumoniaThrombosisCOVID-19 Acute Respiratory Distress Syndrome+1 more
NMC Specialty Hospital 435